SCHMIDT ERIC THOMAS

CIK 00017544033 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001754403

Recent Transactions

50 trades

Award
Revolution Medicines, Inc.$RVMD
Stock Option (Right to Buy)
2023-06-08+18,400→ 18,400 total
Award
Revolution Medicines, Inc.$RVMD
Common Stock
2023-06-08+5,200→ 21,251 total
Award
RELMADA THERAPEUTICS, INC.$RLMD
Stock Option (right to buy)
2023-05-25+92,958→ 150,000 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-03-22+558,094→ 862,439 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2023-03-22+432,738→ 432,738 total
Tax Payment
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-03-14$5.47/sh−35,879→ 304,345 total
Award
RELMADA THERAPEUTICS, INC.$RLMD
Stock Option (right to buy)
2022-12-16+57,042→ 57,042 total
Award
Revolution Medicines, Inc.$RVMD
Stock Option (Right to Buy)
2022-06-16+18,400→ 18,400 total
Award
Revolution Medicines, Inc.$RVMD
Common Stock
2022-06-16+5,200→ 16,051 total
Award
RELMADA THERAPEUTICS, INC.$RLMD
Stock Option (right to buy)
2022-05-25+91,235→ 150,000 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-23+237,358→ 337,904 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2022-03-23+368,589→ 368,589 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-15$7.63/sh−11,469→ 100,546 total
Award
RELMADA THERAPEUTICS, INC.$RLMD
Stock Option (right to buy)
2021-12-17+58,765→ 58,765 total
Award
Revolution Medicines, Inc.$RVMD
Stock Option (Right to Buy)
2021-06-22+12,659→ 12,659 total
Award
Revolution Medicines, Inc.$RVMD
Common Stock
2021-06-22+3,617→ 10,851 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-05-24$18.22/sh+14,897→ 110,994 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-05-24−14,897→ 94,703 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-03-26+24,866→ 96,097 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-03-26+92,365→ 92,365 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-03-15$38.23/sh−8,053→ 71,231 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-01-15$31.69/sh−3,547→ 1,164,048 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-01-15$33.28/sh−400→ 1,152,595 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-01-15$32.40/sh−11,053→ 1,152,995 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-01-14$31.10/sh−5,149→ 1,167,595 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-01-14$30.60/sh−9,851→ 1,172,744 total
Award
RELMADA THERAPEUTICS, INC.$RLMD
Options to purchase common stock
2021-01-07+100,000→ 100,000 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-11-16$33.00/sh−10,366→ 1,182,595 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-11-16$32.60/sh−4,634→ 1,192,961 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-15$41.33/sh−3,479→ 1,199,794 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-15$40.07/sh−4,218→ 1,203,273 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-15$42.32/sh−2,099→ 1,197,695 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-15$39.47/sh−5,104→ 1,207,491 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-15$43.01/sh−100→ 1,197,595 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-09-21$34.76/sh−9,889→ 1,217,706 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-09-21$35.96/sh−3,200→ 1,214,506 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-09-21$37.04/sh−1,911→ 1,212,595 total
Award
Revolution Medicines, Inc.$RVMD
Common Stock
2020-06-17+7,234→ 7,234 total
Award
Revolution Medicines, Inc.$RVMD
Stock Option (Right to Buy)
2020-06-17+25,318→ 25,318 total
Exercise of In-Money
RELMADA THERAPEUTICS, INC.$RLMD
Common Stock
2020-04-09$9.00/sh+12,500→ 100,000 total
Exercise of In-Money
RELMADA THERAPEUTICS, INC.$RLMD
Warrants to purchase common stock
2020-04-09$6.00/sh−32,500→ 0 total
Exercise of In-Money
RELMADA THERAPEUTICS, INC.$RLMD
Warrants to purchase common stock
2020-04-09$9.00/sh−12,500→ 0 total
Exercise of In-Money
RELMADA THERAPEUTICS, INC.$RLMD
Common Stock
2020-04-09$6.00/sh+32,500→ 87,500 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-18+30,800→ 78,706 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-03-18+109,600→ 109,600 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-16$20.25/sh−300→ 47,906 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-16$19.70/sh−5,150→ 47,257 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-02-20$25.30/sh−237,155→ 1,227,595 total
Award
Allogene Therapeutics, Inc.$ALLO
Employee Stock Option (Right to Buy)
2019-03-13+83,500→ 83,500 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-03-13+49,400→ 49,400 total

Companies

Recent Filings

Address

210 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov